investor.ariad.com investor.ariad.com

investor.ariad.com

ARIAD Pharmaceuticals, Inc: Investor home

ARIAD Pharmaceuticals, Inc

http://investor.ariad.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.ARIAD.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 7 reviews
5 star
4
4 star
0
3 star
3
2 star
0
1 star
0

Hey there! Start your review of investor.ariad.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT INVESTOR.ARIAD.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
ARIAD Pharmaceuticals, Inc: Investor home | investor.ariad.com Reviews
<META>
DESCRIPTION
ARIAD Pharmaceuticals, Inc
<META>
KEYWORDS
1 ARIAD Pharmaceuticals
2 Inc
3
4 coupons
5 reviews
6 scam
7 fraud
8 hoax
9 genuine
10 deals
CONTENT
Page content here
KEYWORDS ON
PAGE
about ariad,our destination,company leadership,board of directors,our locations,pressroom,grants and donations,photo gallery,video gallery,iclusig,about iclusig,ariad pass,healthcare professionals,patients and caregivers,research and development,pipeline
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

ARIAD Pharmaceuticals, Inc: Investor home | investor.ariad.com Reviews

https://investor.ariad.com

ARIAD Pharmaceuticals, Inc

INTERNAL PAGES

investor.ariad.com investor.ariad.com
1

ARIAD Pharmaceuticals, Inc. :: News releases

http://investor.ariad.com/phoenix.zhtml?c=118422&p=irol-newsArticle&ID=2047982&highlight=

Our Name and Logo. Our Vision, Mission and Values. About @ARIADPharm on Twitter. CML and Ph ALL. Stock quote and chart. Our Vision, Mission and Values. Science and Research Videos. Key to long-term value: discipline, execution and consistent communication. ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting. BUSINESS WIRE)- May 14, 2015-. ARIAD Pharmaceuticals, Inc. NASDAQ: ARIA) today announced that clinical data on Iclusig. American Society of Clinical Oncology. May 29 to June 2, 2015.

2

ARIAD Pharmaceuticals, Inc. :: News releases

http://investor.ariad.com/phoenix.zhtml?c=118422&p=irol-newsArticle&ID=2045292&highlight=

Our Name and Logo. Our Vision, Mission and Values. About @ARIADPharm on Twitter. CML and Ph ALL. Stock quote and chart. Our Vision, Mission and Values. Science and Research Videos. Key to long-term value: discipline, execution and consistent communication. ARIAD Reports First Quarter 2015 Financial Results and Progress on Strategic Objectives. Conference Call Scheduled Today at. BUSINESS WIRE)- May 7, 2015-. ARIAD Pharmaceuticals, Inc. Harvey J. Berger. 2015 First Quarter Financial Results. March 31, 2015.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

SOCIAL ENGAGEMENT



OTHER SITES

investor.appliedmicro.com investor.appliedmicro.com

AppliedMicro - Powering Your Cloud Network - Investor Relations - Investor Relations

Applied Micro Circuits Corporation at Oppenheimer Technology, Internet and Communications Conference. 160;at 10:25 am ET. Applied Micro Circuits Corporation at Oppenheimer Technology, Internet and Communications Conference. Wednesday, August 12, 2015 . 10:25 am ET  . Click here for webcast. Click here to add this event to your calendar. Applied Micro Circuits Corporation at Canaccord Genuity Growth Conference. 160;at 11:00 am ET. Applied Micro Circuits Corporation at Canaccord Genuity Growth Conference.

investor.aqxpharma.com investor.aqxpharma.com

Investor Relations - Aquinox Pharmaceuticals, Inc

Activate excellence. Activate innovation. Activate success. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Aquinox Pharmaceutical Inc's financial performance into perspective. Aquinox Pharmaceuticals Announces Positive Results From Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Reports Second Quarter 2015 Financial Results. View all press releases ». 8/13/15 at 3:00 PM ET.

investor.aradigm.com investor.aradigm.com

Investor Relations | Aradigm Corporation

Skip to main navigation. Mar 29, 2018. Transfer Agent and Registrar. Communications concerning stock transfer requirements, lost certificates and change of address should be directed to:. Shareholder correspondence should be mailed to:. College Station, TX 77842-3170. Overnight correspondence should be sent to:. 211 Quality Circle, Suite 210. College Station, TX 77845. Https:/ www-us.computershare.com/investor/Contact. Mar 23, 2018. Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results.

investor.arbutusbio.com investor.arbutusbio.com

Arbutus Biopharma - Investor Relations

The Baruch S. Blumberg Institute. Surface Antigen Secretion Inhibitors. Oncology, Anti-virals and Metabolic Programs. RNAi Collaborators and Partners. HBV Collaborators and Partners. Arbutus Biopharma is a publicly-traded ( NASDAQ:TKMR. In addition to our HBV Assets. We are developing a pipeline of Oncology, Anti-viral and Metabolic Programs. That leverage our expertise in RNA interference (RNAi). Therapeutics and our Lipid Nanoparticle (LNP). View all ». Aug 7, 2015. Aug 5, 2015. View all ».

investor.archcoal.com investor.archcoal.com

Arch Coal, Inc. | Investors: Investor Relations Home

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Arch Coal's performance into perspective. Arch Coal is listed on the New York Stock Exchange (NYSE: ACI) and maintains its corporate headquarters in St. Louis, Mo. Arch Coal, Inc. Reports Second Quarter 2015 Results. Supplemental Historical Information Regional Realization and Cost Analysis. 2014 Annual Report Narrative. Or www.amstock.com.

investor.ariad.com investor.ariad.com

ARIAD Pharmaceuticals, Inc: Investor home

Our Name and Logo. Our Vision, Mission and Values. Our Vision, Mission and Values. Key to long-term value: discipline, execution and consistent communication. ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer an...

investor.arinet.com investor.arinet.com

Investors — Investor Information - ARI

ARI - We Create Connections. ARI has helped us support the 9 manufacturer brands we sell which has been. Essential to our growth. Our OEM part sales are up 265%. From last year.". Mdash; Powersports Dealer. Services for the Powersports industry. Up-to-date information from all of my manufacturers is critical to my business. Working with ARI saves us more than $450 per week. In outsourcing fees while growing my parts business by 125%. Mdash; OPE Dealer. Services for the Outdoor Power Equipment industry.

investor.aripaev.ee investor.aripaev.ee

AP investor

LHV Maailma Aktsiad Fond A. LHV Maailma Aktsiad Fond B. Nordea Pensionifond Aktsiad 100. Danske Pension 100 Pluss. Mandatum Life Indonesia Index. Mandatum Life Australia Index. Mandatum Life Russia Index. Mandatum Life Brazil Index. Mandatum Life India Index. Hetkel tehinguid sooritatud pole. Nordea Pensionifond A Pluss. NASDAQ OMX Tallinna, Riia ja Vilniuse börsiinfo 15 minutilise viivisega. Info uuendamiseks kasuta "uuenda/refresh" nuppu lehe pealkirja vasakus servas.

investor.arlp.com investor.arlp.com

Alliance Resource Partners, L.P. »Overview

Safety and Technology  . Mines and Facilities  . Community Involvement  . Alliance in the Community. Career Opportunities  . Investor Relations  . About Us  . Coal: Fuel for Economic Growth. Alliance Resource Partners, L.P. Guidance Update. 160;at 11:00 am ET. Alliance Resource Partners, L.P. Guidance Update. Monday, August 3, 2015 . 11:00 am ET  . Click here for webcast. Second Quarter 2015 Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Earnings Conference Call. 160;at 9:00 am ET. Repli...

investor.armourreit.com investor.armourreit.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

investor.arraybiopharma.com investor.arraybiopharma.com

Array BioPharma :: Investors :: Investors

Q4 2015 Array BioPharma Inc. Earnings Conference Call. 160;at 9:00 am ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca). Stock Quote and Chart.